Access cutting-edge glycogen storage disease type ii treatment through this clinical trial at a research site in Little Rock. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Little Rock location
Preparing your pre-screening questions…
Access glycogen storage disease type ii specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related glycogen storage disease type ii treatment provided free
Check if you qualify for this glycogen storage disease type ii clinical trial in Little Rock, AR
No-Cost Study Care
Local to Little Rock
Convenient for AR residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The Pompe Registry is a global, multicenter, international, longitudinal, observational, and voluntary program for patients with Pompe disease, designed to track the disease's natural history and outcomes in patients, both treated and not. Data from the Registry are also used to fulfill various global regulatory commitments, to support product development/reimbursement, and for other research and non-research related purposes. The objectives of the Registry are: * To enhance understanding of the variability, progression, identification, and natural history of Pompe disease, with the ultimate goal of better guiding and assessing therapeutic intervention. * To assist the Pompe medical community with the development of recommendations for monitoring patients, and to provide reports on patient outcomes, to optimize patient care. * To characterize the Pompe disease population. * To evaluate the long-term effectiveness of alglucosidase alfa.
Sponsor: Genzyme, a Sanofi Company
Yes, this clinical trial (NCT00231400) has an active research site in Little Rock, AR that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for glycogen storage disease type ii treatment options in Little Rock, AR, this clinical trial (NCT00231400) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Little Rock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced glycogen storage disease type ii specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all glycogen storage disease type ii clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Little Rock — not just this study.
Browse Pulmonary Embolism Trials in Little Rock →